Publications by authors named "Ralph Schiess"

Claim this Profile
A
A High Performing Biomarker Signature for Detecting Early-Stage Pancreatic Ductal Adenocarcinoma in High-Risk Individuals.
Norma A Palma, Aimee L Lucas, Bryson W Katona, Alcibiade Athanasiou, Natasha M Kureshi, Ralph Schiess

Cancers (Basel)· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biomarker Discovery for Early Detection of Pancreatic Ductal Adenocarcinoma (PDAC) Using Multiplex Proteomics Technology.
Alcibiade Athanasiou, Natasha Kureshi, Anja Wittig, Maria Sterner, Ramy Huber, Ralph Schiess

J Proteome Res· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of Proclarix in the diagnostic work-up of prostate cancer.
Basil Kaufmann, Sharon Fischer, Alcibiade Athanasiou, Noémie Lautenbach, Anja Wittig, Ralph Schiess

BJUI Compass· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Accurate diagnosis of prostate cancer by combining Proclarix with magnetic resonance imaging.
Juan Morote, Hayley Pye, Miriam Campistol, Anna Celma, Lucas Regis, Ralph Schiess

BJU Int· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
New strategy for the identification of prostate cancer: The combination of Proclarix and the prostate health index.
Daniela Terracciano, Evelina La Civita, Alcibiade Athanasiou, Antonietta Liotti, Mariano Fiorenza, Ralph Schiess

Prostate· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PROPOSe: A Real-life Prospective Study of Proclarix, a Novel Blood-based Test to Support Challenging Biopsy Decision-making in Prostate Cancer.
Thomas Steuber, Isabel Heidegger, Mona Kafka, Martin A Roeder, Felix Chun, Ralph Schiess

Eur Urol Oncol· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use of MS-GUIDE for identification of protein biomarkers for risk stratification of patients with prostate cancer.
Sandra Goetze, Peter Schüffler, Alcibiade Athanasiou, Anika Koetemann, Cedric Poyet, Ralph Schiess

Clin Proteomics· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A novel serum biomarker quintet reveals added prognostic value when combined with standard clinical parameters in prostate cancer patients by predicting biochemical recurrence and adverse pathology.
Alcibiade Athanasiou, Pierre Tennstedt, Anja Wittig, Ramy Huber, Oliver Straub, Ralph Schiess

PLoS One· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Analytical performance of thrombospondin-1 and cathepsin D immunoassays part of a novel CE-IVD marked test as an aid in the diagnosis of prostate cancer.
Annalisa Macagno, Alcibiade Athanasiou, Anja Wittig, Ramy Huber, Stephan Weber, Ralph Schiess

PLoS One· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development and validation of a novel multivariate risk score to guide biopsy decision for the diagnosis of clinically significant prostate cancer.
Helmut Klocker, Bruno Golding, Stephan Weber, Eberhard Steiner, Pierre Tennstedt, Ralph Schiess

BJUI Compass· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Thrombospondin 1 and cathepsin D improve prostate cancer diagnosis by avoiding potentially unnecessary prostate biopsies.
Thomas Steuber, Pierre Tennstedt, Annalisa Macagno, Alcibiade Athanasiou, Anja Wittig, Ralph Schiess

BJU Int· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Similarities and Differences of Blood N-Glycoproteins in Five Solid Carcinomas at Localized Clinical Stage Analyzed by SWATH-MS.
Tatjana Sajic, Yansheng Liu, Eirini Arvaniti, Silvia Surinova, Evan G Williams, Ralph Schiess

Cell Rep· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development and clinical testing of individual immunoassays for the quantification of serum glycoproteins to diagnose prostate cancer.
Kathrin Endt, Jens Goepfert, Aurelius Omlin, Alcibiade Athanasiou, Pierre Tennstedt, Ralph Schiess

PLoS One· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A mass spectrometric-derived cell surface protein atlas.
Damaris Bausch-Fluck, Andreas Hofmann, Thomas Bock, Andreas P Frei, Ferdinando Cerciello, Ralph Schiess

PLoS One· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metformin in chemotherapy-naive castration-resistant prostate cancer: a multicenter phase 2 trial (SAKK 08/09).
Christian Rothermundt, Stefanie Hayoz, Arnoud J Templeton, Ralph Winterhalder, Räto T Strebel, Ralph Schiess

Eur Urol· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 2 trial of single-agent everolimus in chemotherapy-naive patients with castration-resistant prostate cancer (SAKK 08/08).
Arnoud J Templeton, Valérie Dutoit, Richard Cathomas, Christian Rothermundt, Daniela Bärtschi, Ralph Schiess

Eur Urol· July 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
N-glycoprotein SRMAtlas: a resource of mass spectrometric assays for N-glycosites enabling consistent and multiplexed protein quantification for clinical applications.
Ruth Hüttenhain, Silvia Surinova, Reto Ossola, Zhi Sun, David Campbell, Ralph Schiess

Mol Cell Proteomics· April 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of cetuximab in metastatic castration-resistant prostate cancer might depend on EGFR and PTEN expression: results from a phase II trial (SAKK 08/07).
Richard Cathomas, Christian Rothermundt, Dirk Klingbiel, Lukas Bubendorf, Rolf Jaggi, Ralph Schiess

Clin Cancer Res· November 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A DNA-damage selective role for BRCA1 E3 ligase in claspin ubiquitylation, CHK1 activation, and DNA repair.
Ko Sato, Elayanambi Sundaramoorthy, Eeson Rajendra, Hiroyoshi Hattori, Anand D Jeyasekharan, Ralph Schiess

Curr Biol· September 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PASSEL: the PeptideAtlas SRMexperiment library.
Terry Farrah, Eric W Deutsch, Richard Kreisberg, Zhi Sun, David S Campbell, Ralph Schiess

Proteomics· April 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comprehensive description of the N-glycoproteome of mouse pancreatic β-cells and human islets.
Carsten Danzer, Katrin Eckhardt, Alexander Schmidt, Niklaus Fankhauser, Sebastien Ribrioux, Ralph Schiess

J Proteome Res· March 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Defining potentially conserved RNA regulons of homologous zinc-finger RNA-binding proteins.
Tanja Scherrer, Christian Femmer, Ralph Schiess, Ruedi Aebersold, André P Gerber

Genome Biol· February 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel prognostic markers in the serum of patients with castration-resistant prostate cancer derived from quantitative analysis of the pten conditional knockout mouse proteome.
Martin Kälin, Igor Cima, Ralph Schiess, Niklaus Fankhauser, Tom Powles

Eur Urol· December 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biomarker validation in blood specimens by selected reaction monitoring mass spectrometry of N-glycosites.
Reto Ossola, Ralph Schiess, Paola Picotti, Oliver Rinner, Lukas Reiter

Methods Mol Biol· July 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cancer genetics-guided discovery of serum biomarker signatures for diagnosis and prognosis of prostate cancer.
Igor Cima, Ralph Schiess, Peter Wild, Martin Kaelin, Peter Schüffler

Proc Natl Acad Sci U S A· February 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis